ICD-10-PCS Billable Code

CH11YZZ

Planar Nuclear Medicine Imaging Breast, Left to None with None, Other Radionuclide Approach

Procedural Specifications

Clinical Axis Detail Definition
SectionC Nuclear Medicine
Body SystemH Skin, Subcutaneous Tissue and Breast
Operation1 Planar Nuclear Medicine Imaging
Body Part1 Breast, Left
ApproachY Other Radionuclide
DeviceZ None
QualifierZ None

Operation Definition

Introduction of radioactive materials into the body for single plane display of images developed from the capture of radioactive emissions

Procedure Overview

This family covers single-plane radioactive imaging of the skin, subcutaneous tissue, and breast, most commonly lymphoscintigraphy performed to map lymphatic drainage before breast cancer or melanoma surgery. A radioactive tracer, typically technetium-99m sulfur colloid, is injected near the tumor or biopsy site, and a gamma camera captures flat images as the tracer travels through lymphatic channels toward the first draining lymph nodes.

Surgeons use these images to identify and mark the sentinel lymph node, the first node a tumor would spread to, so it can be removed and examined during surgery instead of removing an entire chain of lymph nodes unnecessarily. The scan is typically done the same day as surgery or the day before, and the images are often paired with a handheld gamma probe used in the operating room to physically locate the marked node.

Anatomy & Axis Detail

Breast, Left

For the left breast, planar nuclear medicine imaging typically serves the same lymphoscintigraphic purpose as its right-sided counterpart, mapping tracer drainage from a peritumoral injection site to sentinel nodes before biopsy or surgery. The left breast's proximity to the heart and mediastinum occasionally requires attention to background radioactivity when interpreting images, since cardiac blood pool activity can be mistaken for or obscure adjacent nodal uptake. As with any planar study, the output is a two-dimensional projection rather than a sectional dataset, sufficient for the binary question of whether and where a sentinel node has taken up tracer. Accurate laterality documentation is essential, since this code is reserved for studies confined to the left breast alone rather than bilateral evaluation.

Radionuclide: Other Radionuclide

Other Radionuclide is used when a nuclear medicine study employs a radioactive tracer that does not correspond to one of the specifically named isotope values in this axis, such as an uncommon or newer radiopharmaceutical. It functions as a catch-all so the procedure can still be coded precisely by section and root operation even when the exact tracer lacks its own dedicated code value.

Coding & Documentation

A code from this family requires documentation of the tracer injection near the breast or skin lesion and confirmation that flat, single-position images were obtained showing lymphatic drainage pathways and node uptake, without a rotational SPECT component. The most frequent coding error is applying this code when only the intraoperative gamma probe was used to find the node, since the probe-guided localization without preceding preoperative planar imaging does not meet this root operation. Another common mistake is misclassifying the body system when the drainage pattern documented actually centers on a lymph node basin elsewhere in the body rather than the breast or skin site itself.

Commonly Confused With

This family is frequently confused with Tomographic Nuclear Medicine Imaging when a SPECT/CT lymphoscintigraphy was performed instead of a planar-only study, since SPECT/CT gives better anatomic localization in obese patients or complex drainage patterns. It is also distinguished from Lymphatic and Hemic System nuclear medicine imaging, which applies when the primary structure being evaluated is a lymph node group unrelated to a breast or skin lesion rather than the drainage from a skin or breast site.